NCT06398977View on ClinicalTrials.gov

Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 11, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Peritoneal Dialysis ComplicationRenal Function AggravatedSodium-glucose Co-transporter-2 Inhibitors
Interventions
DRUG

Dapagliflozin

Dapagliflozin10MG, PO once daily

Trial Locations (1)

610000

RECRUITING

Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospita, Chengdu

All Listed Sponsors
lead

Sichuan Academy of Medical Sciences

OTHER